Nephrology evaluation · KIMS Secunderabad
Proteinuria (Protein in Urine) — What It Means, What Causes It, and When It Signals Kidney Disease
Protein in the urine — detected as foamy or frothy urine, or found on a routine urine test — is one of the earliest and most important warning signs of kidney disease. Healthy kidneys act as selective filters: they allow waste products to pass into the urine but retain proteins — particularly albumin, which is too large to pass through the intact glomerular filtration barrier. When the filtering barrier is damaged, protein leaks through. The amount of protein in the urine, how long it has been present, and what other signs accompany it determine both the underlying cause and the urgency of treatment.
Most people with proteinuria feel completely well. There are no symptoms from mild to moderate protein leakage — only the visual sign of foamy urine, or the incidental finding on a urine dipstick at a health check or diabetic review. This is precisely why proteinuria is missed — and why, by the time it is investigated, significant kidney damage may already have accumulated. At KIMS Secunderabad, proteinuria detected at any stage is taken seriously: it is investigated systematically, the underlying cause is identified, and treatment is started to slow or stop the progression before irreversible damage occurs.
Why protein in the urine matters — the mechanism
The glomerular filtration barrier. The kidney's filtering unit — the glomerulus — contains a three-layer filtration barrier: the endothelium, the glomerular basement membrane, and the podocytes (specialised cells on the outer surface of the glomerular capillaries). These three layers together prevent proteins as large as albumin (molecular weight 66 kDa) from passing into the filtrate. When this barrier is disrupted — by immune-mediated inflammation, by the pressure of hypertension, by the metabolic effects of diabetes, or by direct podocyte injury — albumin and other proteins leak through.
The cardiovascular consequence. The clinical consequences of sustained heavy protein leakage go beyond the kidneys. Persistent proteinuria is one of the strongest independent risk factors for cardiovascular disease — a fact that is underappreciated by many patients and even some clinicians. A person with proteinuria above 1 gram per day has a cardiovascular risk comparable to that of a person who has already had a heart attack. The mechanisms include endothelial dysfunction from the filtered proteins, the underlying inflammatory processes that cause both proteinuria and vascular injury, and the secondary hypertension that accelerates both kidney and cardiovascular damage.
How proteinuria is measured
Several different urine tests are used to detect and quantify proteinuria. Each has a specific role — from rapid screening to precise quantification for diagnosis and monitoring. KIMS uses these tests in combination based on the clinical question being asked.
Urine dipstick
Qualitative — traces protein on a colour-change strip. Grades: trace, 1+, 2+, 3+, 4+. Useful as a screening test. Not quantitative — positive dipstick requires confirmation with ACR or PCR. Can be falsely positive with very concentrated urine.
Albumin-to-Creatinine Ratio (ACR) — spot urine
Quantifies albumin excretion relative to creatinine (to adjust for urine concentration). Result in mg/mmol. Normal: below 3. Microalbuminuria: 3–30. Macroalbuminuria: above 30. The recommended test for CKD monitoring and diabetic nephropathy screening. Can be performed on a first-morning or random urine sample.
Protein-to-Creatinine Ratio (PCR) — spot urine
Quantifies total protein (not just albumin) relative to creatinine. Result in mg/mmol. Normal: below 15. Above 100 indicates significant proteinuria; above 350 indicates nephrotic-range proteinuria. Used when total protein (not just albumin) measurement is clinically important — e.g. non-albumin proteins in myeloma.
24-hour urine protein
Collects all urine over 24 hours and measures total daily protein excretion. Gold standard for quantifying proteinuria — used for diagnosis, risk stratification, and monitoring treatment response in glomerular disease. Normal: below 150 mg/day. Nephrotic range: above 3,500 mg/day (3.5 g/day).
Causes of proteinuria — from benign to serious
Not all proteinuria reflects kidney disease. The first step in any proteinuria workup is to distinguish transient causes — which are usually benign and resolve without treatment — from persistent causes that require systematic investigation and long-term management.
Transient (non-persistent) proteinuria — usually benign
Several non-pathological causes produce temporary proteinuria that resolves without treatment:
Orthostatic proteinuria — protein leaks into the urine only when standing (not when lying down). Common in adolescents and young adults, almost always benign. Confirmed by comparing first-morning (recumbent) urine ACR with daytime (standing) urine ACR. No treatment required.
Fever and acute illness — transient proteinuria is common during febrile illness, resolving as the illness clears. Re-test urine 4 to 6 weeks after recovery.
Vigorous exercise — particularly endurance sports can cause transient proteinuria that resolves within 24 to 48 hours.
Concentrated urine — very concentrated urine can give a false positive on dipstick. Confirmed by specific gravity or osmolality measurement.
Persistent proteinuria — requires investigation
Each persistent cause of proteinuria has a distinct mechanism, clinical pattern, and management pathway. The cards below summarise the key features for each — they form the basis for the systematic diagnostic workup at KIMS.
Diabetic nephropathy
The most common cause of persistent proteinuria in India. Microalbuminuria (ACR 3–30) is the first detectable marker of diabetic kidney disease, appearing years before creatinine rises. Progression to macroalbuminuria (ACR above 30) indicates established nephropathy. Management: SGLT2 inhibitors, ACE inhibitors/ARBs, HbA1c control below 7%.
Hypertensive nephrosclerosis
Sustained high blood pressure damages the glomerular arterioles, causing progressive proteinuria and CKD. Management: blood pressure below 130/80, ACE inhibitor or ARB as first-line.
Primary glomerulonephritis
IgA nephropathy, membranous nephropathy, FSGS, minimal change disease, and other immune-mediated conditions directly injure the glomerular filtration barrier. Proteinuria is the primary clinical marker. Kidney biopsy is required for definitive diagnosis and to guide treatment.
Nephrotic syndrome
Massive proteinuria above 3.5 grams per day with hypoalbuminaemia, oedema, and hyperlipidaemia. The clinical endpoint of severe glomerular barrier damage from multiple possible underlying causes.
CKD from any cause
As kidney function declines from any cause, the adaptive hyperfiltration in remaining nephrons increases the stress on the glomerular filtration barrier, causing proteinuria that further accelerates CKD progression — a self-reinforcing cycle.
Lupus nephritis
Systemic lupus erythematosus causes immune complex deposition in the glomeruli. Proteinuria with haematuria and declining eGFR in a woman of reproductive age should prompt ANA and anti-dsDNA testing alongside kidney biopsy.
Multiple myeloma and paraproteinaemias
Light chains produced by malignant plasma cells are filtered by the glomerulus and can cause proteinuria and direct tubular toxicity (cast nephropathy). Protein electrophoresis and free light chain measurement are important additional tests in the proteinuria workup of patients above 50.
The investigation pathway at KIMS
At KIMS, proteinuria is investigated systematically — the goal is to establish whether it is transient or persistent, quantify it precisely, and identify the underlying cause. The standard workup:
Urine ACR or PCR on two or three separate samples
To confirm persistence and establish the degree of proteinuria.
24-hour urine protein
For precise quantification and baseline for monitoring treatment response.
Serum creatinine, eGFR, full blood count
Kidney function assessment and baseline.
Random blood glucose, HbA1c
To screen for diabetic nephropathy.
Serum protein electrophoresis (SPEP) and free light chains
In patients above 50, to exclude paraproteinaemia as a cause.
ANA, anti-dsDNA, complement (C3 and C4)
In patients with clinical features suggesting lupus.
Anti-PLA2R antibody
Highly specific for primary membranous nephropathy. If positive, confirms the diagnosis without requiring immediate biopsy in low-risk cases.
Kidney biopsy with NABL LM + IF + EM
For persistent proteinuria above 0.5 g/day with no clear cause, for rapidly increasing proteinuria, or where the ACR + clinical picture suggests glomerulonephritis. At KIMS, all three pathological components are performed in-house.
Treatment — depends entirely on the cause
Proteinuria is a sign, not a disease. Its treatment is the treatment of the underlying cause — there is no single 'proteinuria treatment.' However, several interventions reduce proteinuria across multiple causes and provide kidney protection regardless of the specific diagnosis.
ACE inhibitors or ARBs
Reduce intraglomerular pressure, decrease proteinuria, and slow CKD progression independently of blood pressure reduction. First-line treatment for proteinuria from diabetic nephropathy, hypertensive nephrosclerosis, and IgA nephropathy.
SGLT2 inhibitors
Dapagliflozin and empagliflozin reduce proteinuria and kidney failure risk in CKD with proteinuria (DAPA-CKD, EMPA-KIDNEY trials). Standard of care for diabetic CKD and increasingly used in non-diabetic CKD with proteinuria.
Blood pressure control
Target below 130/80 mmHg for patients with proteinuria. More intensive targets (below 125/75) in patients with high-grade proteinuria.
Sodium restriction
Dietary sodium restriction to below 2 grams per day reduces proteinuria and enhances the antiproteinuric effect of ACE inhibitors and ARBs.
Disease-specific immunosuppression
For primary glomerulonephritis diagnosed on biopsy: prednisolone, rituximab, tacrolimus, cyclophosphamide as directed by the specific diagnosis.
If you have diabetes or hypertension, ask your doctor to check your urine albumin-to-creatinine ratio (ACR) and eGFR at your next appointment if these have not been checked in the past 12 months. Both tests together take 5 minutes and identify early kidney disease when it is still treatable. KIMS includes ACR and eGFR in every diabetic and hypertensive patient review.
Book a Proteinuria Assessment at KIMS
Frequently Asked Questions — Proteinuria
Foamy or frothy urine — foam that persists for more than 30 seconds in the toilet bowl after urinating — is the most common symptom that prompts patients with proteinuria to seek medical attention. It is caused by protein in the urine lowering the surface tension of the urine, producing foam in the same way that detergent produces foam in water. Not all foamy urine indicates serious kidney disease — very concentrated urine from dehydration can also appear foamy. But persistent foam that appears consistently, especially combined with leg swelling, warrants a urine protein test without delay.
Proteinuria from a treatable underlying cause can resolve completely with effective treatment. Diabetic nephropathy at the microalbuminuria stage can revert to normal with intensive glucose control, ACE inhibitor therapy, and SGLT2 inhibitors. Primary membranous nephropathy treated with rituximab achieves complete or partial remission in the majority of patients. Proteinuria from hypertensive nephrosclerosis reduces significantly with blood pressure control. Proteinuria from established, advanced CKD cannot be fully reversed — but progression can be slowed significantly and, in some cases, stabilised for years or decades.
Healthy kidneys excrete a very small amount of protein in the urine — below 150 milligrams per day on a 24-hour collection, or below 15 mg/mmol on a urine PCR. This normal protein excretion is primarily Tamm-Horsfall protein from the tubules, not albumin from the glomeruli. The albumin-specific measurement — urine ACR — is below 3 mg/mmol in a healthy person. An ACR above 3 mg/mmol (microalbuminuria range) detected on two separate occasions constitutes abnormal proteinuria that warrants investigation and monitoring.
Not necessarily — but it does mean your kidneys need evaluation. Mild proteinuria (microalbuminuria — ACR 3 to 30 mg/mmol) with normal eGFR is an early warning sign that the kidneys are under stress, particularly in diabetics or hypertensives. At this stage, kidney function is preserved and aggressive treatment can prevent or significantly delay progression to kidney failure. Heavy proteinuria (nephrotic range — above 3.5 g/day) with a declining eGFR indicates established kidney disease that requires urgent nephrologist evaluation and biopsy to guide treatment.
Microalbuminuria describes albumin leakage above normal but below the threshold detectable by standard urine dipstick — ACR 3 to 30 mg/mmol. It is the earliest detectable sign of diabetic nephropathy and hypertensive nephrosclerosis. Macroalbuminuria (also called overt proteinuria or clinical proteinuria) is albumin leakage detectable on standard dipstick — ACR above 30 mg/mmol. Macroalbuminuria indicates established glomerular damage and carries a significantly higher risk of progression to kidney failure than microalbuminuria. The transition from micro to macroalbuminuria over time signals accelerating disease and should prompt intensification of all kidney-protective measures.
Proteinuria during pregnancy is a significant clinical finding. New-onset proteinuria (ACR above 30 mg/mmol or PCR above 30 mg/mmol) after 20 weeks of gestation, combined with hypertension, defines pre-eclampsia — a serious pregnancy complication requiring specialist obstetric management and, in KIMS's context, nephrology co-management. Proteinuria in early pregnancy is more likely to reflect pre-existing kidney disease that has been unmasked by the haemodynamic changes of pregnancy. Any proteinuria detected during pregnancy — at any stage — requires prompt medical evaluation.
Kidney biopsy is indicated for proteinuria when: the cause is not established by non-invasive investigations (ACR, ANA, anti-PLA2R antibody, eGFR trajectory), the proteinuria is above 0.5 to 1 gram per day and persistent, the proteinuria is accompanied by haematuria (suggesting glomerulonephritis), or the proteinuria is increasing despite first-line treatment. Kidney biopsy at KIMS uses real-time ultrasound guidance, local anaesthetic, a same-day discharge protocol, and NABL-accredited pathology with light microscopy, immunofluorescence, and electron microscopy — all three components in-house with results in 5 to 7 working days.
KIMS Secunderabad — Dr. V. S. Reddy (senior transplant nephrologist, 20+ years at KIMS), Dr. Aswini Dutt T (glomerular disease subspecialty — IgA nephropathy, membranous nephropathy, FSGS, lupus nephritis), NABL-accredited kidney biopsy (LM + IF + EM in-house), systematic proteinuria workup including SGLT2 inhibitor protocol, anti-PLA2R antibody testing, 24-hour urine collection.